BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 11854201)

  • 21. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes.
    Koga M; Yuki N; Takahashi M; Saito K; Hirata K
    J Neuroimmunol; 1998 Jan; 81(1-2):138-43. PubMed ID: 9521615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequence typing confirms that Campylobacter jejuni strains associated with Guillain-Barré and Miller-Fisher syndromes are of diverse genetic lineage, serotype, and flagella type.
    Dingle KE; Van Den Braak N; Colles FM; Price LJ; Woodward DL; Rodgers FG; Endtz HP; Van Belkum A; Maiden MC
    J Clin Microbiol; 2001 Sep; 39(9):3346-9. PubMed ID: 11526174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fisher syndrome associated with IgG anti-GQ1b antibody following infection by a specific serotype of Campylobacter jejuni.
    Ohtsuka K; Nakamura Y; Hashimoto M; Tagawa Y; Takahashi M; Saito K; Yuki N
    Ophthalmology; 1998 Jul; 105(7):1281-5. PubMed ID: 9663234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3.
    Salloway S; Mermel LA; Seamans M; Aspinall GO; Nam Shin JE; Kurjanczyk LA; Penner JL
    Infect Immun; 1996 Aug; 64(8):2945-9. PubMed ID: 8757818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guillain Barré Syndrome is induced in Non-Obese Diabetic (NOD) mice following Campylobacter jejuni infection and is exacerbated by antibiotics.
    St Charles JL; Bell JA; Gadsden BJ; Malik A; Cooke H; Van de Grift LK; Kim HY; Smith EJ; Mansfield LS
    J Autoimmun; 2017 Feb; 77():11-38. PubMed ID: 27939129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipopolysaccharides from Campylobacter jejuni O:41 strains associated with Guillain-Barré syndrome exhibit mimicry of GM1 ganglioside.
    Prendergast MM; Lastovica AJ; Moran AP
    Infect Immun; 1998 Aug; 66(8):3649-55. PubMed ID: 9673245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recognition characteristics of monoclonal antibodies that are cross-reactive with gangliosides and lipooligosaccharide from Campylobacter jejuni strains associated with Guillain-Barré and Fisher syndromes.
    Houliston RS; Yuki N; Hirama T; Khieu NH; Brisson JR; Gilbert M; Jarrell HC
    Biochemistry; 2007 Jan; 46(1):36-44. PubMed ID: 17198373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry.
    Koga M; Gilbert M; Li J; Koike S; Takahashi M; Furukawa K; Hirata K; Yuki N
    Neurology; 2005 May; 64(9):1605-11. PubMed ID: 15883324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Campylobacter jejuni from patients with Guillain-Barré syndrome preferentially expresses a GD(1a)-like epitope.
    Nachamkin I; Liu J; Li M; Ung H; Moran AP; Prendergast MM; Sheikh K
    Infect Immun; 2002 Sep; 70(9):5299-303. PubMed ID: 12183587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain-Barre syndrome (GBS).
    Gregson NA; Rees JH; Hughes RA
    J Neuroimmunol; 1997 Mar; 73(1-2):28-36. PubMed ID: 9058756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barré syndrome.
    Yuki N; Handa S; Tai T; Takahashi M; Saito K; Tsujino Y; Taki T
    J Neurol Sci; 1995 May; 130(1):112-6. PubMed ID: 7544402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain-Barré syndrome and Miller Fisher syndrome.
    Heikema AP; Jacobs BC; Horst-Kreft D; Huizinga R; Kuijf ML; Endtz HP; Samsom JN; van Wamel WJ
    Clin Microbiol Infect; 2013 Feb; 19(2):E106-12. PubMed ID: 23173866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacterial infections in Guillain-Barré and Fisher syndromes.
    Yuki N; Koga M
    Curr Opin Neurol; 2006 Oct; 19(5):451-7. PubMed ID: 16969154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-GQ1b-negative Miller Fisher syndrome after Campylobacter jejuni enteritis.
    Lee KY
    Pediatr Neurol; 2012 Sep; 47(3):213-5. PubMed ID: 22883289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis.
    Koga M; Gilbert M; Takahashi M; Li J; Koike S; Hirata K; Yuki N
    J Infect Dis; 2006 Feb; 193(4):547-55. PubMed ID: 16425134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of Guillain-Barré syndrome following a family outbreak of Campylobacter jejuni enteritis.
    Ang CW; van Doorn PA; Endtz HP; Merkies IS; Jacobs BC; de Klerk MA; van Koningsveld R; van der Meché FG
    J Neuroimmunol; 2000 Nov; 111(1-2):229-33. PubMed ID: 11063843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome.
    Neisser A; Bernheimer H; Berger T; Moran AP; Schwerer B
    Infect Immun; 1997 Oct; 65(10):4038-42. PubMed ID: 9317004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections.
    Hao Q; Saida T; Kuroki S; Nishimura M; Nukina M; Obayashi H; Saida K
    J Neuroimmunol; 1998 Jan; 81(1-2):116-26. PubMed ID: 9521613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
    Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N
    J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.
    Goodyear CS; O'Hanlon GM; Plomp JJ; Wagner ER; Morrison I; Veitch J; Cochrane L; Bullens RW; Molenaar PC; Conner J; Willison HJ
    J Clin Invest; 1999 Sep; 104(6):697-708. PubMed ID: 10491405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.